Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Expert Opinion on Drug Discovery|March 16, 2013
Advances in the development of AMPK-activating compoundsApiradee Sriwijitkamol, Nicolas Musi
The Journal of Clinical Endocrinology and Metabolism|January 25, 2007
Relationship between vascular reactivity and lipids in Mexican-Americans with type 2 diabetes treated with pioglitazoneEstela Wajcberg, Apiradee Sriwijitkamol, Nicolas Musi, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 15, 2005
LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of trainingApiradee Sriwijitkamol, John L Ivy, Christine Christ-Roberts, et al.
Case Reports in Endocrinology|January 4, 2017
A 33-Year-Old Man with Gynaecomastia and Galactorrhea as the First Symptoms of Graves HyperthyroidismSomdul Khoohaphatthanakul, Apiradee Sriwijitkamol
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|August 14, 2008
Incretins: the novel therapy of type 2 diabetesNuntakon Thongtang, Apiradee Sriwijitkamol
Vascular Health and Risk Management|November 26, 2015
Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University HospitalTamon Sangsawang, Apiradee Sriwijitkamol
Frontiers in Physiology|September 5, 2024
Short-term HIIT impacts HDL function differently in lean, obese, and diabetic subjectsLin Zhu, Julia An, Thao Luu, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 13, 2008
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetesAntonio Cervera, Estela Wajcberg, Apiradee Sriwijitkamol, et al.
Pageof 17